Mink Therapeutics Inc (INKT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Mink Therapeutics Inc   (NASDAQ: INKT)

Mink Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




INKT Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q3 MRQ) 0 % 73.86 % 55.66 % 38 %
Gross Margin (Q3 TTM) 0 % 65.97 % 55.54 % 37.65 %
Gross Profit Margin 5 Yr. Avg. - 64.93 % 54.71 % 32.75 %
EBITDA Margin (Q3 MRQ) 0 % 46.71 % 25.08 % 26.28 %
EBITDA Margin (Q3 TTM) 72.82 % 31.48 % 23.62 % 20.75 %
EBITDA Margin 5 Yr. Avg. - 24.73 % 30.23 % 22.74 %
Operating Margin (Q3 MRQ) -1318.63 % 19.5 % 18.42 % 16.63 %
Operating Margin (Q3 TTM) -5720.68 % 5.07 % 16.41 % 15.69 %
Operating Margin 5 Yr. Avg. - 10.57 % 14.36 % 15.96 %
Pre-Tax Profit Margin (Q3 MRQ) 0 % 27.77 % 14.44 % 13.79 %
Pre-Tax Profit Margin (Q3 TTM) 0 % 14.18 % 12.5 % 12.56 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.3 % 10.83 % 11.56 %
Net Margin (Q3 MRQ) -1276.14 % 21.4 % 10.81 % 10.54 %
Net Margin (Q3 TTM) -5512.49 % 10.01 % 10.57 % 10.17 %
Net Margin 5 Yr. Avg. - 4.43 % 6.8 % 9.04 %



Business Segment Profit Margin
 
Pre-Commercial Product Revenue
  Explore Pre-Commercial Product Revenue Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) -2573.88 % -8.51 % 2.89 % -0.07 %
Free Cash Flow Margin (Q3 TTM) -5518.48 % 17.48 % 13.53 % 8.82 %
Free Cash Flow Margin 5 Yr. Avg. - 18.07 % 17.59 % 16.03 %
Net Cash Flow Margin (Q3 MRQ) 0 % -26.11 % -1.18 % -1.72 %
Net Cash Flow Margin (Q3 TTM) 0 % 3.67 % 1.5 % 0.91 %
Net Cash Flow Margin 5 Yr. Avg. - 9.67 % 4.29 % 11.75 %
Effective Tax Rate (Q3 MRQ) - 23.03 % 24.32 % 21.95 %
Effective Tax Rate (Q3 TTM)